trial · primary record
Curalin
Type2 Diabetes
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2022-05-01 |
| Primary endpoint | Effect of treatment with Curalin on the change in plasma HbA1c |
| Registry ID | NCT05439473 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:38.146Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05439473
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.